M2D Global Life Sciences
Generated 5/9/2026
Executive Summary
M2D Global Life Sciences is a specialized consulting and services firm headquartered in San Diego, California, that provides strategic and operational support to biopharmaceutical and medical device companies. Founded in 2015, the company focuses on pharmacovigilance, quality assurance, clinical development, and regulatory affairs, helping clients navigate complex global regulations and achieve compliance. By serving as an external expert partner, M2D assists both emerging and established life sciences organizations in building functional capabilities, preparing for regulatory inspections, and optimizing their drug development and post-market surveillance processes. The firm’s deep expertise in pharmacovigilance and regulatory affairs positions it as a critical resource in an increasingly stringent regulatory environment, particularly as global health authorities intensify scrutiny on drug safety and quality systems.
Upcoming Catalysts (preview)
- Q2 2026Expansion into EU MDR consulting services70% success
- Q4 2026Strategic partnership with a top-20 pharma company for pharmacovigilance outsourcing40% success
- Q1 2027Launch of AI-enabled pharmacovigilance analytics platform30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)